Indian pharma industry continues to face headwinds
According to ICRA, aggregate growth in pharma sector is expected to come down to single digit
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Dermatology space to benefit most from five potential blockbusters
According to GBI Research, Dupixent is expected to face very little competition and as a result will generate the second highest…
Long-term goal of PvPI is to develop e-reporting and reporting culture among HCPs
Dr GN Singh, DCG(I) and Secretary-cum-Scientific Director, IPC and Dr V Kalaiselvan, Principal Scientific Officer, IPC, in an…
We are interested in exploring opportunities in upcoming pharma cities
Ashish Pruthi, CMD, Rajasthan Antibiotics Limited (RAL), in an interaction with Prathiba Raju, elaborates on how APIs has become…
IPM clocks Rs 115,644 Crs in May 2017
The anti-diabetic market continued with a strong growth of 21 per cent valued at Rs 790 crores
Signet & Roquette conduct technical seminar across four cities
The seminar aimed to impart knowledge about Roquette’s excipients used for solubilisation, coating, oral films and other novel…
A wake up call for serialisation laggards
Pharma companies exporting to the US market who had their eye on the November 2017 deadline to comply with the US Drug Supply…
Express Pharma (Vol.12, No.18) July 16-31, 2017
India's Foremost Pharma & Biotech Magazine
Lupin recalls 12,480 bottles of anti-depressant drug from US market
The product is used for the treatment of depression, panic disorder and social anxiety disorder
Aurobindo Pharma receives approval for Sevelamer Carbonate tabs
Sevelamer Carbonate tablets is indicated for the control of serum phosphorus in patients with chronic kidney disease on dialysis